James O. Gesling joined the Food and Drug Administration (FDA) in 1956, when he graduated from Northwest Missouri State College. He was an inspector in the FDA Kansas City District at first. Beginning in 1968, he was assistant director for regulations and administration of the FDA’s Bureau of Veterinary Medicine. He later became the Executive Officer of the Bureau of Veterinary Medicine.
When the Division of Biologics Standards (DBS) moved to the FDA in 1972, Gesling became the Associate Director for Management and Compliance at what was then called the Bureau of Biologics.
Dive
class
grid-col-4
Image Added
Dive
preface
class
grid-row grid-gap
Dive
class
grid-col-4
Under Gesling the Bureau of Biologics launched a comprehensive investigation of the nation’s plasma businesses, closing dozens for dangerous practices and passing new regulations to address industry operations that put donors and recipients of plasma products at risk.
Info
Gesling worked in Building 29, Room 130.
Dive
class
grid-col-4
Image Removed
8
Image Modified
Span
class
caption
Newspaper clipping which refers to the FDA's activities in regulating blood plasma to protect donors and recipients.